Trends in Cancer (@trendscancer) header
Trends in Cancer (@trendscancer) profile picture

Trends in Cancer is a leading reviews journal covering advances in cancer research and oncology published by Cell Press. Tweets by Editor Danielle Loughlin.

Cambridge, MA
Joined September 2015
Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)Photo by Trends in Cancer (@trendscancer)
Trends in Cancer retweeted
Engineering T cells for immunotherapy vs cancer had already had marked success in certain types. But there's a next generation in the hopper, as reviewed today @Cancer_Cell, that ought to help take the field much further into solid tumors cell.com/cancer-cell/fulltex…
9
77
9
280
31,097
Trends in Cancer retweeted
Thrilled to share our new paper in Science! 🎉 We uncover how dietary fat–driven ceramide synthesis activates YAP-dependent regenerative programs to promote colorectal cancer metastasis, independently of primary tumor growth.congrats @SwagataGoswam16 doi.org/10.1126/science.adw8…
2
20
1
122
6,600
Trends in Cancer retweeted
Pulling out all the stops vs pancreatic cancer. The recent FDA-approved, celebrated drug daraxonrasib, increased median survival by 6.5 months @RevMedicines That's a positive step but clearly not enough. This new @Cancer_Cell paper lays out a path for more. cell.com/cancer-cell/fulltex…
12
53
2
222
29,099
Trends in Cancer retweeted
EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery dlvr.it/TVWFDk
1
32
100
6,474
Trends in Cancer retweeted
CDK4/6 inhibitors arrest the cell cycle by activating Rb. But the authors provide compelling evidence that the story does not end there. A new Nature study shows that hypophosphorylated Rb unexpectedly enhances ER-mediated transcription. Rb relocates to enhancer regions and reactivates proliferative ER-target genes, including CCND1. So, paradoxically, CDK4/6 inhibition leads to: E2F ↓ → proliferation ↓ but at the same time Rb → ER transcription ↑ → proliferative counter-response ↑ Endocrine therapy shuts down this second pathway. This finding reveals a new mechanism that may help explain the strong biological rationale for combining CDK4/6 inhibition with endocrine therapy, while also pointing to a potential mechanism of resistance. nature.com/articles/s41586-0…
2
43
1
118
8,806
Trends in Cancer retweeted
Our paper is out in @Cancer_Cell! We started this project almost 5 years ago with the idea that to understand why some cancer patients respond to immunotherapy and others do not, we may need to look beyond the tumor before treatment. Immunotherapy is not just a test of a pre-existing state; it is a perturbation. It changes the tumor immune microenvironment. So the question became: can the direction of that change explain response? authors.elsevier.com/a/1niWC…
11
99
6
416
24,382
Trends in Cancer retweeted
New paper from @BiffiGiulia in @NatureCellBio comparing fibroblast diversity and epithelial–stromal interactions between #pancreatitis and #PancreaticCancer using a plethora of sample types across species. Congratulations Giulia! nature.com/articles/s41556-0…
1
8
33
2,757
Trends in Cancer retweeted
#RareCancers face massive bottlenecks: limited patient material, few models, and slow screening pipelines. In our new Forum article in @TrendsCancer, we propose a "Zebrafish-First Triage Strategy" to rapidly model, test, and prioritize targets. cell.com/trends/cancer/fullt…
1
2
1
1
298
Trends in Cancer retweeted
Final version of @NeehaZaidi paper on Mutant KRAS Vaccine for #PancreaticCancer interception in high risk cohorts out in @CD_AACR. aacrjournals.org/cancerdisco… Notable data is detection of KRAS antigen targeted T cells 1 year post vaccine - annual boosters as a prevention strategy?
2
24
63
4,625
Trends in Cancer retweeted
Pancreatic cancer is notoriously hard to treat, but we are making progress. Recent @theNCI -funded work that sheds light on mechanisms behind #daraxonrasib resistance and could help clinicians choose treatment combos that outsmart pancreatic tumors. go.nih.gov/AcvCu95
5
29
1
113
6,637
Trends in Cancer retweeted
Now online! Spatial biology reveals altered macrophage states in immunosuppressed non-melanoma skin cancer dlvr.it/TTt4xv
15
73
9,994
Trends in Cancer retweeted
Our paper is out today in Cancer Discovery: Systematic Targeting of Protein Complexes with Molecular COUPLrs. What if, instead of simply inhibiting proteins, we could design small molecules that permanently staple two proteins together aacrjournals.org/cancerdisco…
2
21
1
68
6,533
Trends in Cancer retweeted
3 papers in @Nature today reflecting large scale efforts at mapping dependencies and multimodal molecular profiling data from a large panel of patient-derived 3D cancer models. This is DepMap on steroids! nature.com/articles/s41586-0… nature.com/articles/s41586-0… nature.com/articles/s41586-0…
3
85
3
323
44,846
Trends in Cancer retweeted
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance @CellCellPress cell.com/cell/fulltext/S0092… @BoyiGan @MDAndersonNews
18
1
43
2,568
Trends in Cancer retweeted
Excited to see the @CellPressNews #HallmarksOfCancer Symposium 2026 bring together such an exceptional group of scientists and clinicians in Sitges, Spain From tumor evolution and microenvironment to AI, spatial biology, and translational cancer science, this looks like a timely and important meeting for the field. #CancerResearch #Oncology cell-press-symposia.com/hall…
1
8
27
3,148
Trends in Cancer retweeted
Online Now: High-plasticity oncofetal cell states in early pre-metastatic colorectal cancer dlvr.it/TT51Kg
1
26
2
90
6,922
Trends in Cancer retweeted
Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes dlvr.it/TSz5Qh
25
51
3,693
Trends in Cancer retweeted
A holy grail for our lab has been tracking myeloid cells in human tumors in the same way that we track T and B cells with TCR/BCR. @vincentzliu and @CalebLareau solved it! We developed Mitotrek using scATAC-seq + mitochondrial DNA to do exactly this. Using Mitotrek, we find that new myeloid cells clones constantly infiltrate the tumor via circulating monocytes — and that their macrophage or dendritic cell fate is epigenetically programmed before tumor entry. @10xGenomics @parkerici @CancerResearch @TheMarkFdn cell.com/cancer-cell/fulltex…
8
100
2
360
36,869